Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey

CompletedOBSERVATIONAL
Enrollment

1,053

Participants

Timeline

Start Date

August 14, 2020

Primary Completion Date

June 21, 2023

Study Completion Date

June 21, 2023

Conditions
Atrial Fibrillation
Interventions
DRUG

Edoxaban

Edoxaban according to Package Information (Summary of Product Characteristics \[SmPC\]).

Trial Locations (45)

Unknown

Başkent University Alanya Practice and Research Hospital, Cardiology Clinic, Antalya

Ordu University Training and Research Hospital, Ordu

Dokuz Eylül University Research and Practice Hospital, Department of Cardiology, Izmir

Ege University Hospital, Department of Cardiology, Izmir

Ankara City Hospital, Cardiology Clinic, Ankara

Izmir Çiğli Regional Training Hospital, Cardiology Clinic, Izmir

Aydın Adnan Menderes University Practice and Research Hospital, Department of Cardiology, Aydin

Private Medinova Hospital, Cardiology Clinic, Aydin

Istanbul Bezmialem Foundation University, Faculty of Medicine Hospital, Cardiology Clinic, Istanbul

Health Sciences University Samsun Training and Research Hospital, Cardiology Clinic, Samsun

Başkent University İzmir Zübeyde Hanım Practice and Research Hospital, Cardiology Clinic, Izmir

Medical Park Izmir Hospital, Cardiology Clinic, Izmir

Muğla Sıtkı Koçman University Training and Research Hospital, Department of Cardiology, Muğla

Muğla Yücelen Ortaca Hospital, Cardiology Clinic, Muğla

Balıkesir University Health Practice and Research Hospital, Cardiology Clinic, Balıkesir

Çanakkale Mehmet Akif Ersoy State Hospital, Cardiology Clinic, Çanakkale

Çanakkale Onsekiz Mart University Health Application and Research Hospital, Department of Cardiology, Çanakkale

Tokat Gaziosmanpaşa University, Health Research and Practice Center, Cardiology Department, Tokat Province

Yozgat City Hospital, Cardiology Clinic, Yozgat

Bursa City Hospital, Cardiology Clinic, Bursa

Konya Numune Hospital, Cardiology Clinic, Konya

Istanbul Şişli Hamidiye Etfal Training and Research Hospital, Cardiology Clinic, Istanbul

Eskisehir Umit Private Hospital, Cardiology Clinic, Eskişehir

Mersin City Training and Research Hospital, Cardiology Clinic, Mersin

Van Yüzüncü Yıl University, Dursun Odabaş Medical Center, Van

Başkent University Istanbul Health Practice and Research Center Hospital, Department of Cardiology, Istanbul

Manisa Celal Bayar University Hafsa Sultan Hospital, Department of Cardiology, Manisa

Adana City Training and Research Hospital, Cardiology Clinic, Adana

Aksaray Üniversitesi Eğitim Araştırma Hastanesi, Aksaray

Ankara Üniversitesi Tıp Fakültesi, Ankara

Bayındır Söğütözü Hastanesi, Ankara

Medicana International Ankara Hastanesi, Ankara

Özel Koru Sincan Hastanesi, Ankara

Eskişehir Şehir Hastanesi, Eskişehir

Dr. Ersin Arslan Eğitim ve Araştırma Hastanesi, Gaziantep

Özel Giresun Ada Hastanesi, Giresun

Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi, Istanbul

İstanbul Bahçelievler Devlet Hastanesi, Istanbul

İstanbul Kartal Koşuyolu Yüksek İhtisas EAH, Istanbul

İstanbul Mehmet Akif Ersoy Göğüs Kalp ve Damar Cerrahisi EAH, Istanbul

İstanbul Yedikule Göğüs Hastalıkları ve Göğüs Cerrahisi EAH, Istanbul

Erciyes Üniversitesi Tıp Fakültesi, Kayseri

Manisa Akhisar Mustafa Kirazoğlu Devlet Hastanesi, Manisa

Tekirdağ Şehir Hastanesi, Tekirdağ

Trabzon Ahi Evren Göğüs Kalp ve Damar Cerrahisi EAH, Trabzon

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Daiichi Sankyo

INDUSTRY

lead

Daiichi Sankyo Turkey, a Daiichi Sankyo Company

INDUSTRY

NCT04594915 - Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey | Biotech Hunter | Biotech Hunter